NASDAQ:CDNA - CareDx Stock Price, Price Target & More

$9.45 +0.25 (+2.72 %)
(As of 04/23/2018 04:00 PM ET)
Previous Close$9.45
Today's Range$9.21 - $9.48
52-Week Range$0.76 - $9.48
Volume159,825 shs
Average Volume317,056 shs
Market Capitalization$267.49 million
P/E Ratio-12.27
Dividend YieldN/A
Beta0.35

About CareDx (NASDAQ:CDNA)

CareDx logoCareDx, Inc. is a molecular diagnostics company. The Company is focused on the discovery, development and commercialization of clinically differentiated diagnostic surveillance solutions for transplant patients. The Company's commercialized testing solution, the AlloMap heart transplant molecular test (AlloMap), is a gene expression test that helps clinicians monitor and identify heart transplant recipients with stable graft function having a low probability of moderate/severe acute cellular rejection. Its products under development for transplant monitoring include AlloSure, a development-stage transplant surveillance solution, which applies next generation sequencing to detect and quantitate genetic differences between donor-derived cell-free deoxyribonucleic acid (dd-cfDNA) in the blood stream emanating from the donor heart. It offers the AlloMap Score Variability service, which provides complementary information to help personalize long-term care of heart transplant recipients.

Receive CDNA News and Ratings via Email

Sign-up to receive the latest news and ratings for CDNA and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical laboratories
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:CDNA
CUSIPN/A
Phone415-287-2300

Debt

Debt-to-Equity Ratio-3.08%
Current Ratio0.62%
Quick Ratio0.50%

Price-To-Earnings

Trailing P/E Ratio-12.27
Forward P/E Ratio-21.98
P/E GrowthN/A

Sales & Book Value

Annual Sales$48.32 million
Price / Sales5.69
Cash FlowN/A
Price / CashN/A
Book Value($0.21) per share
Price / Book-45.00

Profitability

EPS (Most Recent Fiscal Year)($0.77)
Net Income$-55,460,000.00
Net Margins-114.79%
Return on Equity-349.65%
Return on Assets-22.88%

Miscellaneous

Employees179
Outstanding Shares29,080,000

How to Become a New Pot Stock Millionaire

CareDx (NASDAQ:CDNA) Frequently Asked Questions

What is CareDx's stock symbol?

CareDx trades on the NASDAQ under the ticker symbol "CDNA."

How were CareDx's earnings last quarter?

CareDx (NASDAQ:CDNA) released its quarterly earnings data on Thursday, March, 22nd. The company reported ($0.09) EPS for the quarter, beating the Thomson Reuters' consensus estimate of ($0.15) by $0.06. The firm had revenue of $12.50 million for the quarter, compared to the consensus estimate of $12.09 million. CareDx had a negative net margin of 114.79% and a negative return on equity of 349.65%. View CareDx's Earnings History.

When is CareDx's next earnings date?

CareDx is scheduled to release their next quarterly earnings announcement on Thursday, May, 10th 2018. View Earnings Estimates for CareDx.

What price target have analysts set for CDNA?

4 brokers have issued twelve-month target prices for CareDx's shares. Their forecasts range from $6.50 to $12.00. On average, they expect CareDx's stock price to reach $8.8750 in the next year. View Analyst Ratings for CareDx.

Are investors shorting CareDx?

CareDx saw a drop in short interest in the month of March. As of March 29th, there was short interest totalling 1,164,799 shares, a drop of 78.4% from the March 15th total of 5,387,444 shares. Based on an average daily trading volume, of 889,989 shares, the short-interest ratio is presently 1.3 days. Currently, 6.3% of the company's stock are sold short.

Who are some of CareDx's key competitors?

Who are CareDx's key executives?

CareDx's management team includes the folowing people:
  • Michael D. Goldberg, Independent Chairman of the Board (Age 59)
  • Peter Maag Ph.D., President, Chief Executive Officer, Director (Age 49)
  • Michael Bell, Chief Financial Officer
  • Mitchell J. Nelles Ph.D., Chief Operating Officer (Age 62)
  • John J. Sninsky Ph.D., Chief Scientific Officer (Age 65)
  • Josh DeFonzo, Chief Commercial Officer (Age 34)
  • Matthew J. Meyer, Chief Business Officer (Age 46)
  • James P. Yee M.D., Ph.D., Chief Medical Officer
  • George W. Bickerstaff III, Independent Director (Age 62)
  • Fred E. Cohen Ph.D. M.D., Independent Director (Age 60)

Has CareDx been receiving favorable news coverage?

News articles about CDNA stock have trended somewhat positive on Monday, Accern Sentiment Analysis reports. Accern identifies negative and positive media coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. CareDx earned a media sentiment score of 0.12 on Accern's scale. They also assigned headlines about the company an impact score of 45.99 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the immediate future.

Who are CareDx's major shareholders?

CareDx's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE (3.90%). Company insiders that own CareDx stock include James P Yee, Michael Brian Bell, Mitchell J Nelles, Neil Gagnon and Peter Maag. View Institutional Ownership Trends for CareDx.

How do I buy shares of CareDx?

Shares of CDNA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is CareDx's stock price today?

One share of CDNA stock can currently be purchased for approximately $9.45.

How big of a company is CareDx?

CareDx has a market capitalization of $267.49 million and generates $48.32 million in revenue each year. The company earns $-55,460,000.00 in net income (profit) each year or ($0.77) on an earnings per share basis. CareDx employs 179 workers across the globe.

How can I contact CareDx?

CareDx's mailing address is 3260 BAYSHORE BOULEVARD, BRISBANE CA, 94005. The company can be reached via phone at 415-287-2300 or via email at [email protected]


MarketBeat Community Rating for CareDx (CDNA)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  154 (Vote Outperform)
Underperform Votes:  146 (Vote Underperform)
Total Votes:  300
MarketBeat's community ratings are surveys of what our community members think about CareDx and other stocks. Vote "Outperform" if you believe CDNA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CDNA will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

CareDx (NASDAQ:CDNA) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
4 Wall Street analysts have issued ratings and price targets for CareDx in the last 12 months. Their average twelve-month price target is $8.8750, suggesting that the stock has a possible downside of 6.08%. The high price target for CDNA is $12.00 and the low price target for CDNA is $6.50. There are currently 4 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $8.8750$8.8750$8.8750$7.8333
Price Target Upside: 6.08% downside48.41% upside32.46% upside39.38% upside

CareDx (NASDAQ:CDNA) Consensus Price Target History

Price Target History for CareDx (NASDAQ:CDNA)

CareDx (NASDAQ:CDNA) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/12/2018HC WainwrightSet Price TargetBuy$12.00HighView Rating Details
10/9/2017Craig HallumReiterated RatingBuy$4.00 -> $10.00N/AView Rating Details
9/27/2017Raymond JamesUpgradeMarket Perform -> Buy$6.50HighView Rating Details
9/26/2017Piper JaffrayReiterated RatingOverweight$3.00 -> $7.00HighView Rating Details
6/14/2016Leerink SwannReiterated RatingBuyN/AView Rating Details
6/14/2016MizuhoBoost Price TargetBuy$8.00 -> $12.00N/AView Rating Details
(Data available from 4/23/2016 forward)

Earnings

CareDx (NASDAQ:CDNA) Earnings History and Estimates Chart

Earnings by Quarter for CareDx (NASDAQ:CDNA)

CareDx (NASDAQ:CDNA) Earnings Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181($0.17)($0.17)($0.17)
Q3 20181($0.09)($0.09)($0.09)
Q4 20181($0.08)($0.08)($0.08)

CareDx (NASDAQ CDNA) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/10/2018($0.13)N/AView Earnings Details
3/22/2018Q4 2017($0.1450)($0.09)$12.09 million$12.50 millionViewListenView Earnings Details
11/9/2017Q3 2017($0.17)($0.15)$12.05 million$12.19 millionViewN/AView Earnings Details
8/10/2017Q2 2017($0.19)($0.19)$11.87 million$12.05 millionViewN/AView Earnings Details
6/9/2017Q1 2017($0.27)($0.34)$11.23 million$11.58 millionViewN/AView Earnings Details
4/21/2017Q4 2016($0.15)$10.77 million$10.86 millionViewN/AView Earnings Details
11/9/2016Q3 2016($0.25)($0.17)$11.50 million$12.48 millionViewListenView Earnings Details
8/10/2016Q216($0.28)($0.29)$10.42 million$10.70 millionViewListenView Earnings Details
5/6/2016Q1($0.31)($0.37)$6.97 million$6.60 millionViewN/AView Earnings Details
3/24/2016Q415($0.34)($0.40)$7.44 million$6.60 millionViewListenView Earnings Details
11/11/2015Q315($0.25)($0.29)$7.34 million$7.15 millionViewListenView Earnings Details
8/10/2015Q215($0.18)($0.27)$7.28 million$7.13 millionViewListenView Earnings Details
5/12/2015Q115($0.17)($0.19)$6.82 million$7.22 millionViewListenView Earnings Details
11/10/2014Q314($0.13)$0.01$6.60 million$6.65 millionViewN/AView Earnings Details
8/27/2014Q2 14($0.13)($0.09)$6.18 million$6.78 millionViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

CareDx (NASDAQ:CDNA) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

CareDx (NASDAQ CDNA) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 5.40%
Institutional Ownership Percentage: 51.50%
Insider Trading History for CareDx (NASDAQ:CDNA)
Insider Trading History for CareDx (NASDAQ:CDNA)

CareDx (NASDAQ CDNA) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/27/2018Peter MaagInsiderSell15,000$7.87$118,050.00272,037View SEC Filing  
12/8/2017James P YeeInsiderSell29,197$7.00$204,379.0074,795View SEC Filing  
11/30/2017Mitchell J NellesCOOSell10,948$7.17$78,497.1684,225View SEC Filing  
10/5/2017Neil GagnonMajor ShareholderBuy10,642$4.00$42,568.00View SEC Filing  
9/7/2017Neil GagnonMajor ShareholderBuy6,496$3.05$19,812.80916,546View SEC Filing  
8/28/2017Neil GagnonMajor ShareholderBuy21,448$2.77$59,410.96903,731View SEC Filing  
8/25/2017Neil GagnonMajor ShareholderBuy35,119$2.92$102,547.48890,473View SEC Filing  
8/15/2017Michael Brian BellCFOBuy725$1.83$1,326.75375View SEC Filing  
8/15/2017Peter MaagInsiderBuy600$1.82$1,092.00107,350View SEC Filing  
7/24/2017Neil GagnonMajor ShareholderBuy1,486$1.23$1,827.78886,216View SEC Filing  
6/29/2017Neil GagnonMajor ShareholderBuy1,808$1.11$2,006.88886,216View SEC Filing  
6/23/2017Neil GagnonMajor ShareholderBuy63,120$1.10$69,432.00886,216View SEC Filing  
5/24/2017Neil GagnonMajor ShareholderBuy7,439$1.00$7,439.00879,914View SEC Filing  
5/23/2017Neil GagnonMajor ShareholderBuy6,836$1.04$7,109.44878,777View SEC Filing  
4/28/2017Neil GagnonMajor ShareholderBuy15,116$0.89$13,453.24873,928View SEC Filing  
3/16/2017Neil GagnonMajor ShareholderBuy123,160$1.83$225,382.80778,133View SEC Filing  
9/22/2016Neil GagnonMajor ShareholderBuy178,686$4.00$714,744.00613,473View SEC Filing  
4/14/2016Neil GagnonMajor ShareholderBuy93,240$4.02$374,824.80419,638View SEC Filing  
10/21/2015Neil Gagnonmajor shareholderBuy1,431$4.99$7,140.691,243,852View SEC Filing  
10/20/2015Neil GagnonMajor ShareholderBuy1,347$4.92$6,627.241,242,421View SEC Filing  
9/29/2015Neil Gagnonmajor shareholderBuy6,332$6.10$38,625.201,240,886View SEC Filing  
9/4/2015Neil GagnonMajor ShareholderBuy69,383$6.95$482,211.85View SEC Filing  
6/5/2015Neil GagnonMajor ShareholderBuy6,500$5.69$36,985.00View SEC Filing  
6/1/2015Peter MaagCEOBuy2,000$4.84$9,680.00View SEC Filing  
4/17/2015Neil GagnonMajor ShareholderBuy13,051$5.34$69,692.34View SEC Filing  
3/20/2015Neil GagnonMajor ShareholderBuy6,324$6.35$40,157.40View SEC Filing  
2/27/2015Neil GagnonMajor ShareholderBuy4,270$6.03$25,748.10View SEC Filing  
2/6/2015Neil GagnonMajor ShareholderBuy4,586$7.20$33,019.20View SEC Filing  
2/5/2015Neil GagnonMajor ShareholderBuy121,587$7.10$863,267.70View SEC Filing  
2/4/2015Neil GagnonMajor ShareholderBuy31,991$7.00$223,937.00View SEC Filing  
2/3/2015Neil GagnonMajor ShareholderBuy23,558$7.03$165,612.74View SEC Filing  
2/2/2015Neil GagnonMajor ShareholderBuy3,620$7.05$25,521.00View SEC Filing  
1/29/2015Neil GagnonMajor ShareholderBuy15,395$7.04$108,380.80View SEC Filing  
1/27/2015Neil GagnonMajor ShareholderBuy84,720$7.00$593,040.00View SEC Filing  
1/22/2015Neil GagnonMajor ShareholderBuy48,670$7.13$347,017.10View SEC Filing  
1/20/2015Neil GagnonMajor ShareholderBuy16,192$6.66$107,838.72View SEC Filing  
1/15/2015Neil GagnonMajor ShareholderBuy39,109$6.43$251,470.87View SEC Filing  
1/14/2015Neil GagnonMajor ShareholderBuy122,319$7.07$864,795.33View SEC Filing  
7/22/2014Ken LudlumCFOBuy7,000$10.00$70,000.00View SEC Filing  
7/22/2014Michael GoldbergDirectorBuy25,000$10.00$250,000.00View SEC Filing  
7/22/2014Perkins Caufield & Bye KleinerMajor ShareholderBuy52,770$10.00$527,700.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

CareDx (NASDAQ CDNA) News Headlines

Source:
DateHeadline
Head to Head Comparison: CareDx (CDNA) versus The CompetitionHead to Head Comparison: CareDx (CDNA) versus The Competition
www.americanbankingnews.com - April 22 at 3:16 PM
CareDx (CDNA) Rating Increased to Buy at BidaskClubCareDx (CDNA) Rating Increased to Buy at BidaskClub
www.americanbankingnews.com - April 20 at 11:39 AM
Head to Head Contrast: CareDx (CDNA) versus Its PeersHead to Head Contrast: CareDx (CDNA) versus Its Peers
www.americanbankingnews.com - April 20 at 11:08 AM
BRIEF-Caredx Enters Into A Credit Agreement And Guaranty - SEC FilingBRIEF-Caredx Enters Into A Credit Agreement And Guaranty - SEC Filing
www.reuters.com - April 18 at 9:40 AM
CareDx Closes Debt RefinancingCareDx Closes Debt Refinancing
finance.yahoo.com - April 18 at 9:40 AM
CareDx (CDNA) versus Its Rivals Critical SurveyCareDx (CDNA) versus Its Rivals Critical Survey
www.americanbankingnews.com - April 17 at 7:19 PM
$13.86 Million in Sales Expected for CareDx (CDNA) This Quarter$13.86 Million in Sales Expected for CareDx (CDNA) This Quarter
www.americanbankingnews.com - April 17 at 3:29 AM
Financial Analysis: CareDx (CDNA) and Its CompetitorsFinancial Analysis: CareDx (CDNA) and Its Competitors
www.americanbankingnews.com - April 17 at 3:13 AM
CareDx (CDNA) Rating Lowered to Hold at Zacks Investment ResearchCareDx (CDNA) Rating Lowered to Hold at Zacks Investment Research
www.americanbankingnews.com - April 16 at 9:16 PM
Critical Contrast: CareDx (CDNA) vs. Biocept (BIOC)Critical Contrast: CareDx (CDNA) vs. Biocept (BIOC)
www.americanbankingnews.com - April 16 at 5:19 PM
Critical Contrast: CareDx (CDNA) & Its CompetitorsCritical Contrast: CareDx (CDNA) & Its Competitors
www.americanbankingnews.com - April 15 at 5:15 PM
CareDx (CDNA) Expected to Post Earnings of -$0.12 Per ShareCareDx (CDNA) Expected to Post Earnings of -$0.12 Per Share
www.americanbankingnews.com - April 15 at 1:23 PM
CareDx (CDNA) vs. Its Competitors Critical ReviewCareDx (CDNA) vs. Its Competitors Critical Review
www.americanbankingnews.com - April 13 at 5:21 PM
Financial Contrast: CareDx (CDNA) & Its PeersFinancial Contrast: CareDx (CDNA) & Its Peers
www.americanbankingnews.com - April 13 at 11:51 AM
Olerup QTYPE® Receives CE Mark CertificationOlerup QTYPE® Receives CE Mark Certification
finance.yahoo.com - April 13 at 10:07 AM
CareDx (CDNA) Sees Significant Drop in Short InterestCareDx (CDNA) Sees Significant Drop in Short Interest
www.americanbankingnews.com - April 13 at 2:10 AM
CareDx (CDNA) Stock Rating Reaffirmed by HC WainwrightCareDx (CDNA) Stock Rating Reaffirmed by HC Wainwright
www.americanbankingnews.com - April 12 at 10:45 AM
CareDx (CDNA) Upgraded to C- at TheStreetCareDx (CDNA) Upgraded to C- at TheStreet
www.americanbankingnews.com - April 12 at 10:19 AM
CareDx launches rejection surveillance solution for heart transplant recipientsCareDx launches rejection surveillance solution for heart transplant recipients
seekingalpha.com - April 10 at 4:18 PM
Analyzing CareDx (CDNA) & Its PeersAnalyzing CareDx (CDNA) & Its Peers
www.americanbankingnews.com - April 10 at 11:18 AM
BRIEF-Caredx Launches Heartcare For Heart Transplant RecipientsBRIEF-Caredx Launches Heartcare For Heart Transplant Recipients
www.reuters.com - April 10 at 10:05 AM
CareDx Launches HeartCare® for Heart Transplant RecipientsCareDx Launches HeartCare® for Heart Transplant Recipients
finance.yahoo.com - April 10 at 10:05 AM
CareDx (CDNA) and Its Peers Critical ComparisonCareDx (CDNA) and Its Peers Critical Comparison
www.americanbankingnews.com - April 8 at 3:13 PM
Critical Comparison: CareDx (CDNA) versus Biocept (BIOC)Critical Comparison: CareDx (CDNA) versus Biocept (BIOC)
www.americanbankingnews.com - April 5 at 3:08 AM
Analyzing CareDx (CDNA) and Its CompetitorsAnalyzing CareDx (CDNA) and Its Competitors
www.americanbankingnews.com - April 4 at 9:58 AM
CareDx (CDNA) & Its Peers Head to Head SurveyCareDx (CDNA) & Its Peers Head to Head Survey
www.americanbankingnews.com - April 4 at 1:23 AM
CareDx (CDNA) Upgraded to Buy at ValuEngineCareDx (CDNA) Upgraded to Buy at ValuEngine
www.americanbankingnews.com - April 3 at 5:52 PM
Head-To-Head Comparison: CareDx (CDNA) vs. Its CompetitorsHead-To-Head Comparison: CareDx (CDNA) vs. Its Competitors
www.americanbankingnews.com - April 2 at 5:20 PM
HC Wainwright Analysts Give CareDx (CDNA) a $12.00 Price TargetHC Wainwright Analysts Give CareDx (CDNA) a $12.00 Price Target
www.americanbankingnews.com - April 2 at 9:34 AM
Financial Survey: CareDx (CDNA) versus Its CompetitorsFinancial Survey: CareDx (CDNA) versus Its Competitors
www.americanbankingnews.com - April 2 at 7:33 AM
CareDx (CDNA) Given Consensus Rating of "Buy" by BrokeragesCareDx (CDNA) Given Consensus Rating of "Buy" by Brokerages
www.americanbankingnews.com - April 1 at 8:16 AM
 Analysts Expect CareDx (CDNA) Will Announce Quarterly Sales of $13.86 Million Analysts Expect CareDx (CDNA) Will Announce Quarterly Sales of $13.86 Million
www.americanbankingnews.com - March 31 at 2:28 AM
-$0.12 EPS Expected for CareDx (CDNA) This Quarter-$0.12 EPS Expected for CareDx (CDNA) This Quarter
www.americanbankingnews.com - March 29 at 5:22 PM
CareDx Announces Completion of Debt ConversionCareDx Announces Completion of Debt Conversion
finance.yahoo.com - March 29 at 10:05 AM
CareDx (CDNA) Insider Peter Maag Sells 15,000 SharesCareDx (CDNA) Insider Peter Maag Sells 15,000 Shares
www.americanbankingnews.com - March 28 at 10:46 PM
HC Wainwright Reiterates Buy Rating for CareDx (CDNA)HC Wainwright Reiterates Buy Rating for CareDx (CDNA)
www.americanbankingnews.com - March 26 at 10:58 AM
CareDx (CDNA) Lifted to Hold at ValuEngineCareDx (CDNA) Lifted to Hold at ValuEngine
www.americanbankingnews.com - March 25 at 8:10 PM
CareDx Q4 top line up 15%; profitability expected in H2 2018CareDx Q4 top line up 15%; profitability expected in H2 2018
seekingalpha.com - March 24 at 4:11 PM
CareDx reports 4Q lossCareDx reports 4Q loss
finance.yahoo.com - March 23 at 9:36 AM
Edited Transcript of CDNA earnings conference call or presentation 22-Mar-18 8:30pm GMTEdited Transcript of CDNA earnings conference call or presentation 22-Mar-18 8:30pm GMT
finance.yahoo.com - March 23 at 9:36 AM
CareDx (CDNA) Releases Quarterly  Earnings Results, Beats Expectations By $0.05 EPSCareDx (CDNA) Releases Quarterly Earnings Results, Beats Expectations By $0.05 EPS
www.americanbankingnews.com - March 23 at 8:14 AM
CareDx Reports Fourth Quarter and FY2017 Financial ResultsCareDx Reports Fourth Quarter and FY2017 Financial Results
finance.yahoo.com - March 22 at 4:14 PM
CareDx Inc (CDNA) Expected to Post Quarterly Sales of $12.09 MillionCareDx Inc (CDNA) Expected to Post Quarterly Sales of $12.09 Million
www.americanbankingnews.com - March 14 at 5:03 AM
 Analysts Anticipate CareDx Inc (CDNA) Will Post Earnings of -$0.13 Per Share Analysts Anticipate CareDx Inc (CDNA) Will Post Earnings of -$0.13 Per Share
www.americanbankingnews.com - March 12 at 3:24 PM
CareDx Inc (CDNA) Given Average Recommendation of "Buy" by AnalystsCareDx Inc (CDNA) Given Average Recommendation of "Buy" by Analysts
www.americanbankingnews.com - March 7 at 11:44 AM
920,000 Shares in CareDx Inc (CDNA) Acquired by Stonepine Capital Management LLC920,000 Shares in CareDx Inc (CDNA) Acquired by Stonepine Capital Management LLC
www.americanbankingnews.com - March 6 at 2:56 PM
CareDx to Announce Fourth Quarter and Fiscal Year 2017 Financial Results on March 22, 2018CareDx to Announce Fourth Quarter and Fiscal Year 2017 Financial Results on March 22, 2018
finance.yahoo.com - March 6 at 9:31 AM
Gagnon Securities LLC Decreases Holdings in CareDx Inc (CDNA)Gagnon Securities LLC Decreases Holdings in CareDx Inc (CDNA)
www.americanbankingnews.com - March 3 at 5:10 PM
CareDx Inc (CDNA) Shares Bought by Next Century Growth Investors LLCCareDx Inc (CDNA) Shares Bought by Next Century Growth Investors LLC
www.americanbankingnews.com - March 3 at 3:53 PM
CareDx Inc (CDNA) Shares Bought by Gagnon Advisors LLCCareDx Inc (CDNA) Shares Bought by Gagnon Advisors LLC
www.americanbankingnews.com - March 2 at 5:42 PM

SEC Filings

CareDx (NASDAQ:CDNA) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

CareDx (NASDAQ:CDNA) Income Statement, Balance Sheet and Cash Flow Statement

Chart

CareDx (NASDAQ CDNA) Stock Chart for Monday, April, 23, 2018

Loading chart…

This page was last updated on 4/23/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.